Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer

Intermittent fasting can help patients with type 2 diabetes lose weight and better control their glucose levels. (JAMA Network Open)

How far should doctors go to treat childhood obesity? (New York Times)

The FDA cleared the Omnipod 5 app for iPhone for use with the tubeless automated insulin delivery system, maker Insulet announced.

No causal connection exists between GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and thyroid cancer, a safety panel for the European Medicines Agency concluded. (Reuters)

Therapeutic touch and listening to 30 minutes of music before bed bolstered sleep quality and reduced menopausal symptoms. (Menopause)

Japan’s Supreme Court struck down a law requiring transgender people to undergo sterilization surgery in order to officially change their gender. (AP)

Meanwhile, in the U.S., individuals relocating to states that have prohibited restrictions on gender-affirming care often face long waitlists to see providers. (CBS News)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Please enable JavaScript to view the

comments powered by Disqus.